Drug intelligence / Profile preview

Endofalk

Development stage
Unknown
Lead developer
Dr. Falk Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Endofalk is an osmotic bowel cleansing preparation developed and marketed by Dr. Falk Pharma. It is a combination product containing macrogol 3350 (polyethylene glycol) and a balanced mixture of electrolytes, including sodium chloride, potassium chloride, and sodium bicarbonate. The drug is administered orally as a solution to induce diarrhea, effectively cleansing the gastrointestinal tract prior to colonoscopy or other diagnostic procedures. Macrogol 3350 acts as an osmotic agent that retains water in the bowel, increasing stool volume and stimulating intestinal motility. The inclusion of electrolytes makes the solution isotonic, which helps prevent significant shifts in fluid and electrolyte balance, thereby improving patient safety and tolerability compared to non-isotonic preparations.

Brand names
EndofalkEndofalk ClassicEndofalk Tropic
Other names
macrogol 3350 + electrolytes

Beyond the preview

Go deeper on Endofalk.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endofalk.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call